Showing 1 - 5 results of 5 for search 'Cecilia Lezcano', query time: 0.03s Refine Results
  1. 1
    Novel iatrogenic amyloidosis caused by peptide drug liraglutide: a clinical mimic of AL amyloidosis

    Novel iatrogenic amyloidosis caused by peptide drug liraglutide: a clinical mimic of AL amyloidosis by Carlo O. Martins, Cecilia Lezcano, San S. Yi, Heather J. Landau, Jessica R. Chapman, Ahmet Dogan

    Published 2018-12-01
    Get full text
    Article
  2. 2
    Solar elastosis correlates with high tumor mutation burden and better 5-year disease-specific survival in patients with stage II/III melanoma

    Solar elastosis correlates with high tumor mutation burden and better 5-year disease-specific survival in patients with stage II/III melanoma by Cecilia Lezcano, Li Luo, Ronglai Shen, Irene Orlow, Nancy E. Thomas, Marianne Berwick, Klaus J. Busam

    Published 2024-12-01
    Get full text
    Article
  3. 3
    Use of dupilumab to manage a grade 3 cutaneous adverse effect from enfortumab vedotin/pembrolizumab treatment in a patient with metastatic urothelial carcinoma

    Use of dupilumab to manage a grade 3 cutaneous adverse effect from enfortumab vedotin/pembrolizumab treatment in a patient with metastatic urothelial carcinoma by Maura C. Gillis, BA, Vanessa R. Weir, BA, Cecilia Lezcano, MD, Gopa Iyer, MD, Allison Gordon, MD

    Published 2025-02-01
    Get full text
    Article
  4. 4
    Features of an atypical vascular lesion on dermoscopy, reflectance confocal microscopy, and optical coherence tomography

    Features of an atypical vascular lesion on dermoscopy, reflectance confocal microscopy, and optical coherence tomography by Beatrice Martinez Zugaib Abdalla, MD, Jasmine Posner, BS, Ucalene Harris, BS, Ofer Reiter, MD, Catherine M. Payulert, APP, Cecilia Lezcano, MD, Ashfaq A. Marghoob, MD, Manu Jain, MD

    Published 2023-05-01
    Get full text
    Article
  5. 5
    InterMEL: An international biorepository and clinical database to uncover predictors of survival in early-stage melanoma.

    InterMEL: An international biorepository and clinical database to uncover predictors of survival in early-stage melanoma. by Irene Orlow, Keimya D Sadeghi, Sharon N Edmiston, Jessica M Kenney, Cecilia Lezcano, James S Wilmott, Anne E Cust, Richard A Scolyer, Graham J Mann, Tim K Lee, Hazel Burke, Valerie Jakrot, Ping Shang, Peter M Ferguson, Tawny W Boyce, Jennifer S Ko, Peter Ngo, Pauline Funchain, Judy R Rees, Kelli O'Connell, Honglin Hao, Eloise Parrish, Kathleen Conway, Paul B Googe, David W Ollila, Stergios J Moschos, Eva Hernando, Douglas Hanniford, Diana Argibay, Christopher I Amos, Jeffrey E Lee, Iman Osman, Li Luo, Pei-Fen Kuan, Arshi Aurora, Bonnie E Gould Rothberg, Marcus W Bosenberg, Meg R Gerstenblith, Cheryl Thompson, Paul N Bogner, Ivan P Gorlov, Sheri L Holmen, Elise K Brunsgaard, Yvonne M Saenger, Ronglai Shen, Venkatraman Seshan, Eduardo Nagore, Marc S Ernstoff, Klaus J Busam, Colin B Begg, Nancy E Thomas, Marianne Berwick, InterMEL Consortium

    Published 2023-01-01
    Get full text
    Article

Search Tools: